Clinical Trials in Philadelphia

Showing 16841-16860 of 20,904 trials

Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

NCT00085254

Cilengitide may stop the growth of cancer by stopping blood flow to the tumor. Drugs used in chemotherapy, such as temozolomide, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Radiation therapy uses high-energy x-rays to damage tumor cells. Giving cilengitide together with temozolomide and radiation therapy may kill more tumor cells. This randomized phase I/II trial is studying the side effects and best dose of cilengitide when given together with temozolomide and radiation therapy and to compare how well they work in treating patients with newly diagnosed glioblastoma multiforme

Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma

National Cancer Institute (NCI)112 participantsStarted Apr 2005

Birmingham, Alabama, United States • Atlanta, Georgia, United States • Baltimore, Maryland, United States +5 more locations

COMPLETEDPhase 2< 1 mile

Efficacy Study of Two Continuous Regimens of Oral Daily 5 mg or 10 mg of Ulipristal Acetate (UPA), Versus a Dose of 5.0mg UPA for 24/4 Days

NCT01953679

To compare the pharmacodynamic effects of 2 continuous dose regimens of ulipristal acetate 5.0 and 10.0 mg-only oral contraception, versus a 24/4 day regimen of UPA 5.0 mg.

Focus: Estrogen-free Oral Contraception

Premier Research180 participantsStarted Mar 2014

Los Angeles, California, United States • San Francisco, California, United States • Aurora, Colorado, United States +7 more locations

Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Efficacy Study of Two Continuous Regimens of Oral Daily 5 mg or 10 mg of Ulipristal Acetate (UPA), Versus a Dose of 5.0mg UPA for 24/4 Days

Find Trials by Condition in Philadelphia

GORE Flow Reversal System and GORE Embolic Filter Extension Study

Iodine I 131 Monoclonal Antibody TNT-1/B in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme

Blood and Marrow Transplant Clinical Research Network

Study of Incidence of Respiratory Tract AEs in Patients Treated With Tyvaso® Compared to Other FDA Approved PAH Therapies

Atacicept in Subjects With Optic Neuritis

Minor Increase Over Minimal Risk Research in NICU

ACCELERATE Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With COPEGUS (Ribavirin) in Interferon-Naive Patients With Chronic Hepatitis C (CHC) Infection.

Amyloid Imaging And Safety Study Of ACC-001 In Subjects With Early Alzheimer's Disease

Evaluation of the A1CNow+ Test Kit

Study of an Investigational Glucose Meter System

Cervical Preparation Before Dilation and Evacuation

Comparison of Two Combination Chemotherapy Regimens in Treating Adults With Previously Untreated Leukemia or Lymphoma

Phase I Study of Dasatinib (BMS-354825) and Imatinib in Subjects With Chronic Myeloid Leukemia in Chronic Phase

Intradiscal rhGDF-5 Phase I/II Clinical Trial

A Trial to Assess the Safety, Tolerability, and Immunogenicity of Bivalent rLP2086 Vaccine When Given to Healthy Young Adults Aged >=18 to <26 Years.

12 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Patients With Type 2 Diabetes Mellitus

Safety of Gadovist in Renally Impaired Patients

Safety, Tolerability and Pharmacokinetics of Aerosolized Amikacin in Intubated and Mechanically-ventilated Patients With Nosocomial Pneumonia